SCHEMBL5415705

SCHEMBL5415705

CCOC(=O)c1c(-c2ccccc2)c2ccccc2n1Cc1ccc(N)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 5/20 0.52
MDM2 Q00987 2/20 0.52
HDAC1 Q13547 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
F2RL3 Q96RI0 2/20 0.47
KMT2A Q03164 3/20 0.46
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 2/20 0.45
MDM4 O15151 1/20 0.45
F10 P00742 1/20 0.45
GAA P10253 2/20 0.45
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45
NOD2 Q9HC29 1/20 0.45
NOD1 Q9Y239 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893009 0.88 PLA2G2A (0.51) MAPK8MDM2KMT2AMAPTMDM4
SCHEMBL4886339 0.88 PLA2G2A (0.55) MAPK8MDM2KMT2AMAPTMEN1
SCHEMBL5428229 0.85 AR (0.61) MAPK8MDM2KMT2AMAPTMEN1
SCHEMBL5417706 0.84 FEN1 (0.47) MDM2F2RL3KMT2AMAPTALDH1A1
SCHEMBL13356428 0.82 AR (0.56) MAPK8MDM2F2RL3MAPTALDH1A1
SCHEMBL4887373 0.80 SERPINE1 (0.55) MAPK8KMT2AMAPTGAALMNA
SCHEMBL6858393 0.79 KMT2A (0.51) MAPK8KMT2AMAPTF10
SCHEMBL17625298 0.78 F10 (0.58) HDAC1HDAC6F2RL3KMT2AMAPT
SCHEMBL5173704 0.77 KMT2A (0.50) MAPK8MDM2F2RL3KMT2AMAPT
SCHEMBL5172795 0.77 KMT2A (0.50) MAPK8MDM2KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299125-A1 Substituted indoles WYETH (US) 2007-12-27 US disclosed
US-7268159-B2 Substituted indoles WYETH (US) 2007-09-11 US disclosed
CN-1882537-A Substituted indolecarboxylic acid derivatives and their use as PAI-1 inhibitors WYETH CORP (US) 2006-12-20 CN disclosed
EP-1670758-A1 SUBSTITUTED INDOLE ACID DERIVATIVES AND THEIR USE AS PAI-1 INHIBITORS Wyeth (US) 2006-06-21 EP disclosed
US-20050113438-A1 Substituted indoles WYETH (US) 2005-05-26 US disclosed
WO-2005030717-A1 SUBSTITUTED INDOLE ACID DERIVATIVES AND THEIR USE AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299125-A1 Substituted indoles IDO2, IDO1, INMT MAPK8 3676/4885MDM2 90/4885HDAC1 1446/4885
US-20050113438-A1 Substituted indoles IDO2, IDO1, INMT MAPK8 3676/4885MDM2 90/4885HDAC1 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.